Efektivitas Penggunaan Obat Dislipidemia terhadap Kadar LDL pada Pasien Cardiovaskular Penyebab Stroke

Authors

  • Rahmawati Raising Sekolah Tinggi Ilmu Kesehatan Maluku Husada
  • Oktaviarika Dewi Hermawatiningsih Sekolah Tinggi Ilmu Kesehatan Maluku Husada
  • Wiwi Rumaolat Sekolah Tinggi Ilmu Kesehatan Maluku Husada

DOI:

https://doi.org/10.55123/insologi.v3i4.4013

Keywords:

Dyslipidemia Drugs, Cardiovascular, Statin

Abstract

Dyslipidemia is one of the main risk factors for cardiovascular disease, and cholesterol management therapy has significant benefits in the primary and secondary prevention of coronary heart disease and stroke. Therefore, lipid-lowering therapy, especially using HMG-CoA reductase inhibitors (statins), aims to assess the effectiveness of using statin-class dyslipidemia medications, such as simvastatin and atorvastatin, in reducing LDL levels in cardiovascular patients at X Hospital. This research method uses an observational analytic study with a retrospective research design. This study employs the purposive sampling method. The results of this study show that the majority of patients are female (75%). Based on age grouping, it was found that the highest proportion of patients were aged 56-65 years, accounting for 45%. The use of dyslipidemia drugs that achieved the target LDL reduction ≥ 50% includes Simvastatin 10 mg (33.82%), Simvastatin 20 mg (11.94%), Atorvastatin 10 mg (10.45%), and Atorvastatin 20 mg (41.79%). The most effective drug in achieving the LDL reduction target was Atorvastatin 20 mg.

Downloads

Download data is not yet available.

References

Alexxander, A., Nugroho, A. E., & Pinzon, R. T. (2017). Peranan Obat Golongan Statin Terhadap Luaran Status Fungsional Pasien Stroke Iskemik Berulang Di Rumah Sakit Bethesda Yogyakarta. Berkala Ilmiah Kedokteran Duta Wacana, 2(3), 445. https://doi.org/10.21460/bikdw.v2i3.71

Aman, A. M., Soewondo, P., Soelistijo, S. A., Arsana, P. M., Wismandari, Zufry, H., & Rosandi, R. (2019). Pedoman pengelolaan dislipidemia di Indonesia 2019. In Perkumpulan Endokrinologi Indonesia.

Andersson, T., Nåtman, J., Mourtzinis, G., Bager, J. E., Bengtsson Boström, K., Franzén, S., & Hjerpe, P. (2023). The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes. European Journal of Preventive Cardiology, 30(17), 1883–1894. https://doi.org/10.1093/eurjpc/zwad212

Ariyanti, R., & Besral, B. (2019). Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta. Journal of Lipids, 2019, 1–6. https://doi.org/10.1155/2019/2517013

Erwinanto, Ng, S., Santoso, A., Desandri, D. R., Erika, Sukmawan, R., Wicaksono, S. H., & Pintaningrum, Y. (2022). PANDUAN TATA LAKSANA DISLIPIDEMIA (Nomor 112).

Hermawatiningsih, O. D., & Raising, R. (2023). Pengaruh Polimorfisme P2Y12 Pada Penggunaan Antiplatelet Terhadap Kejadian Stroke Berulang. Parapemikir : Jurnal Ilmiah Farmasi, 12(1), 100. https://doi.org/10.30591/pjif.v12i1.4414

Lardizabal, J. A., & Deedwania, P. C. (2010). Benefits of statin therapy and compliance in high risk cardiovascular patients. Vascular Health and Risk Management, 6(1), 843–853. https://doi.org/10.2147/VHRM.S9474

McIver, L. A., & Siddique, M. S. (2024). Atorvastatin.

Pakpahan, J. E. S., & Hartati, B. (2022). Hubungan dislipidemia dengan kejadian stroke. Holistik Jurnal Kesehatan, 16(6), 542–551. https://doi.org/10.33024/hjk.v16i6.8089

Palmisano, B. T., Zhu, L., & Stafford, J. M. (2017). Role of estrogens in the regulation of liver lipid metabolism. Advances in Experimental Medicine and Biology, 1043(615), 227–256. https://doi.org/10.1007/978-3-319-70178-3_12

Puspaseruni, K. (2021). Tatalaksana Dislipidemia terkait Penyakit Kardiovaskular Aterosklerosis (ASCVD): Fokus pada Penurunan LDL-c. Cermin Dunia Kedokteran, 48(10), 395. https://doi.org/10.55175/cdk.v48i10.1512

Talreja, O., Kerndt, C. C., & Cassagnol, M. (2024). Simvastatin.

Tsankof, A., & Tziomalos, K. (2022). The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke. Diseases, 10(1). https://doi.org/10.3390/diseases10010003

Uda’a, R., Dahliah, Edward Pandu Wiriansya, Rahmawati, & Rezky Putri Indarwati. (2023). Pengaruh Terapi Bekam Terhadap Kadar Kolesterol Total Pada Pasien Hiperkolesterolemia di Klinik Hamdalah Makassar. Fakumi Medical Journal: Jurnal Mahasiswa Kedokteran, 3(8), 563–572. https://doi.org/10.33096/fmj.v3i8.295

Downloads

Published

2024-08-20

How to Cite

Rahmawati Raising, Oktaviarika Dewi Hermawatiningsih, & Wiwi Rumaolat. (2024). Efektivitas Penggunaan Obat Dislipidemia terhadap Kadar LDL pada Pasien Cardiovaskular Penyebab Stroke. INSOLOGI: Jurnal Sains Dan Teknologi, 3(4), 442–448. https://doi.org/10.55123/insologi.v3i4.4013

Issue

Vol. 3 No. 4 (2024): Agustus 2024

Section

Articles

License

Copyright (c) 2024 Rahmawati Raising, Oktaviarika Dewi Hermawatiningsih, Wiwi Rumaolat

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa INSOLOGI (Jurnal Sains dan Teknologi) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada INSOLOGI (Jurnal Sains dan Teknologi).